| 篇名 |
Complications after transrectal ultrasound‑guided prostate biopsy: A 10‑year experience in a single institution |
| 作者 |
Yi‑Ping Chiu, Yi‑Chia Lin, Guang‑Dar Juang, Te‑Fu Tsai, Yi‑Hong Cheng, Kuang‑Yu Chou, Hung‑En Chen, Thomas I‑Sheng Hwang |
| 卷期/出版年月 |
50卷3期 (2017/6) |
| 頁次 |
85-88 |
| 摘要 |
Background: Transrectal ultrasound-guided prostate (TRUS‑P) biopsy is the standard diagnostic procedure for patients with suspected prostate cancer. However, infectious complications can occur.
Purpose: To analyze the patients from a single institution who were hospitalized for infectious complications after TRUS‑P biopsy.
Materials and Methods: From 2003 to 2012, 985 TRUS‑P biopsy procedures were performed in a medical center in Northern Taiwan; among these, 28 patients were admitted for infectious complications following the procedure. A retrospective review of the medical records was performed, and data regarding the demographics, details of infectious complications, and hospital course of these patients were collected.
Results: The median age of the patients was 62 (27–82) years; the comorbidity rate was 57.1% (16/28); the admission rate was 2.8% (28/985). The most common causative pathogen was Escherichia coli. More than half of
the cultured E. coli were not resistant to fluoroquinolones. The median hospital stay was 6 (3–16) days, and one patient was admitted to the intensive care unit. No mortality was observed in this study. Although the number of biopsies increased, no obvious increasing trend in the number of hospitalizations was noted in recent years.
Conclusion: TRUS‑P biopsy can be safely performed, and no obvious increasing trend in infectious complications and resistant strains has been observed in recent years. |
| 關鍵詞 |
Biopsy, prostate, transrectal ultrasound |
| 分類 |
Original Article |
